Ozempic vs. Wegovy vs. Zepbound: What's the Difference? A Pittsburgh Guide

If you have been researching medical weight loss in Pittsburgh, you have almost certainly encountered a confusing alphabet soup of brand names: Ozempic, Wegovy, Mounjaro, Zepbound. Are these the same thing? Different medications entirely? Which one does your doctor prescribe for weight loss?

The confusion is completely understandable, and you are not alone. At Aeternus, we walk every new patient through exactly this conversation. Here is your plain-English guide.

The Two Medications Behind the Brand Names

All four of the most commonly discussed weight loss injections come down to just two active ingredients:

1. Semaglutide — the molecule behind Ozempic and Wegovy

2. Tirzepatide — the molecule behind Mounjaro and Zepbound

Understanding the difference between the *drug* and the *brand name* is the key to cutting through all the noise.

Semaglutide: Ozempic vs. Wegovy

Both Ozempic and Wegovy contain the exact same active ingredient: Semaglutide. The reason they have different names is because they are FDA-approved for different conditions at different doses.

• FDA-approved for Type 2 Diabetes management
• Lower dose range (up to 2 mg weekly)
• Manufactured by Novo Nordisk
• Frequently prescribed "off-label" for weight loss when brand-name Wegovy is unavailable or cost-prohibitive

• FDA-approved specifically for chronic weight management
• Higher dose range (up to 2.4 mg weekly — the dose proven most effective for weight loss)
• Manufactured by Novo Nordisk
• The version your physician will prescribe when treating obesity specifically

Tirzepatide: Mounjaro vs. Zepbound

The same logic applies to Tirzepatide.

• FDA-approved for Type 2 Diabetes management
• Manufactured by Eli Lilly
• Frequently used off-label for weight loss

• FDA-approved specifically for chronic weight management
• Manufactured by Eli Lilly
• The weight-loss version of Mounjaro at the same doses

Semaglutide vs. Tirzepatide: Which Is More Effective?

Both medications work by mimicking GLP-1 (glucagon-like peptide-1), a naturally occurring hormone that suppresses appetite and regulates blood sugar. However, Tirzepatide has a dual-action advantage — it also activates the GIP receptor, producing a synergistic effect that amplifies weight loss results.

• Semaglutide (Wegovy): average 15% body weight reduction over 68 weeks
• Tirzepatide (Zepbound): average 20–22.5% body weight reduction over 72 weeks

By the numbers, Tirzepatide tends to produce more significant weight loss. However, the right choice depends on your personal health history, tolerability, and budget — which is exactly why a physician-led consultation at Aeternus is so important.

What About Compounded Versions?

During periods of FDA-declared drug shortages, FDA-regulated compounding pharmacies are permitted to produce versions of Semaglutide and Tirzepatide at significantly lower costs. At Aeternus, our physicians can discuss whether a compounded alternative is appropriate for your specific situation.

Ready to Find Out Which Medication Is Right for You?

Stop guessing. At Aeternus in Pittsburgh, our physician-led team evaluates your complete metabolic profile and prescribes the exact medication — and dose — that gives you the best possible outcome.

👉 Book your No-Pressure Evaluation at Aeternus Today